When anti-CCR2 treatment for arthritis strikes out.
Yoonsang
Y
Cho
Elias
E
Lolis
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D006801:Humans; D054390:Receptors, CCR2 / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; C515334:CCR2 protein, human; D054390:Receptors, CCR2